Reperfusion Therapy

Reteplase administered early after stroke symptom onset was superior vs. alteplase for improving 90-day disability, a speaker reported.

In a phase 2 trial, reteplase was well tolerated with a similar efficacy and safety profile to that of alteplase as an alternative IV thrombolytic treatment for acute ischemic stroke, researchers reported.